Abstract Details

Title Salvage Therapy with Bendamustine for Temozolomide Refractory Bevacizumab Naïve Recurrent Anaplastic Gliomas: A Prospective Phase II Trial

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 292

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marc Chamberlain, MD (Cascadian Therapeutics) PRESENTER	No disclosure on file
Howard Colman, MD, PhD, FAAN (Huntsman Cancer University of Utah)	No disclosure on file
Jeffrey J. Raizer, MD	No disclosure on file

��ɫ��